Literature DB >> 12387737

Peripheral expression of self-MHC-II influences the reactivity and self-tolerance of mature CD4(+) T cells: evidence from a lymphopenic T cell model.

Avinash Bhandoola1, Xuguang Tai, Michael Eckhaus, Hugh Auchincloss, Karen Mason, Steven A Rubin, Kathryn M Carbone, Zvi Grossman, Amy S Rosenberg, Alfred Singer.   

Abstract

While intrathymic MHC expression influences the specificity of developing thymocytes, we considered that peripheral MHC expression might influence the reactivity of postthymic T cells. We now report for CD4(+) T cells that peripheral MHC-II expression does influence their reactivity and self-tolerance. Upon transfer into MHC-II-deficient lymphopenic hosts, mature CD4(+) T cells were found to acquire an activated memory phenotype and to become: (1) autoreactive against syngeneic MHC-II(+) skin grafts, (2) hyperreactive against third-party MHC-II(+) skin grafts, and (3) functionally dysregulated, resulting in a lymphoproliferative disorder characterized by intraepithelial infiltrations. Peripheral MHC-II expression appeared to influence CD4(+) T cell reactivity by two complementary mechanisms: maintenance of CD4(+)CD25(+) regulatory T cells ("suppression") and direct dampening of CD4(+) T cell reactivity ("tuning").

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12387737     DOI: 10.1016/s1074-7613(02)00417-x

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  36 in total

1.  Cellular therapies supplement: the role of granulocyte macrophage colony-stimulating factor and dendritic cells in regulatory T-cell homeostasis and expansion.

Authors:  Tao Zou; Atsushi Satake; Priti Ojha; Taku Kambayashi
Journal:  Transfusion       Date:  2011-11       Impact factor: 3.157

2.  MHC class II deprivation impairs CD4 T cell motility and responsiveness to antigen-bearing dendritic cells in vivo.

Authors:  Ursula B Fischer; Erica L Jacovetty; Ricardo B Medeiros; Brian D Goudy; Traci Zell; Jeannie-Beth Swanson; Elizabeth Lorenz; Yoji Shimizu; Mark J Miller; Alexander Khoruts; Elizabeth Ingulli
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-13       Impact factor: 11.205

Review 3.  Quantitative challenges in understanding ligand discrimination by alphabeta T cells.

Authors:  Ofer Feinerman; Ronald N Germain; Grégoire Altan-Bonnet
Journal:  Mol Immunol       Date:  2007-09-06       Impact factor: 4.407

Review 4.  Negative regulators in homeostasis of naïve peripheral T cells.

Authors:  Jaime F Modiano; Lisa D S Johnson; Donald Bellgrau
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 5.  Naive T cell homeostasis: from awareness of space to a sense of place.

Authors:  Kensuke Takada; Stephen C Jameson
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

Review 6.  mTOR and other effector kinase signals that impact T cell function and activity.

Authors:  Darienne R Myers; Benjamin Wheeler; Jeroen P Roose
Journal:  Immunol Rev       Date:  2019-09       Impact factor: 12.988

7.  Tonic LAT-HDAC7 Signals Sustain Nur77 and Irf4 Expression to Tune Naive CD4 T Cells.

Authors:  Darienne R Myers; Tannia Lau; Evan Markegard; Hyung W Lim; Herbert Kasler; Minghua Zhu; Andrea Barczak; John P Huizar; Julie Zikherman; David J Erle; Weiguo Zhang; Eric Verdin; Jeroen P Roose
Journal:  Cell Rep       Date:  2017-05-23       Impact factor: 9.423

Review 8.  Indoctrinating T cells to attack pathogens through homeschooling.

Authors:  Caitlin S Parello; Eric S Huseby
Journal:  Trends Immunol       Date:  2015-05-12       Impact factor: 16.687

9.  Alloreactive CD8 T cell tolerance requires recipient B cells, dendritic cells, and MHC class II.

Authors:  Thomas Fehr; Fabienne Haspot; Joshua Mollov; Meredith Chittenden; Timothy Hogan; Megan Sykes
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

10.  Self-class I MHC molecules support survival of naive CD8 T cells, but depress their functional sensitivity through regulation of CD8 expression levels.

Authors:  Kensuke Takada; Stephen C Jameson
Journal:  J Exp Med       Date:  2009-09-14       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.